CTTI Homepage

CTTI Homepage

Modernizing Trials Together

CTTI is the one member-based organization that brings together experts from every facet of the clinical trials enterprise as equal voices to solve the most complex challenges in clinical trials. Through our collaborative and innovative efforts, we are transforming the landscape of clinical trials for participants, researchers, and the public.

CTTI Impact

Disease Progression Modeling

CTTI is advancing the use of disease progression modeling in clinical trials by promoting consistent, data-driven strategies that optimize trial design, enhance decision-making, and accelerate the development of safe, effective treatments for patients.

Learn More

ctti_DPM_banners_home2

CTTI Best Practices & Innovations

  • SafetySafety
    Ensuring the safety and protection of our study participants is ...

  • Patient EngagementPatient Engagement
    Engaging patients and patient organizations as partners early and often ...

  • Ensuring QualityEnsuring Quality
    “Quality” in clinical trials is defined as the absence of ...

CTTI_SOCT_web_banner_26june2025

CTTI Spotlight

Inside the State of Clinical Trials

On May 22, CTTI brought together 150 clinical trials leaders, patients, policy influencers, and researchers in Washington, D.C., for a dynamic and solutions-focused meeting on the state of clinical trials. The event centered on identifying key barriers to progress across the research enterprise and collaboratively exploring actionable solutions. Through interactive breakout sessions, attendees engaged deeply with the five pillars of CTTI’s Transforming Trials 2030 vision, guided by more than 25 expert facilitators from across the field.

Learn More

CTTI Happenings

CTTI News, Publications |

CTTI Publication Provides Recommendations for Disease Progression Modeling in Medical Product Development

Disease progression modeling (DPM) has the potential to support greater efficiency and better decision-making in clinical development, yet it remains underutilized compared with more established model-informed drug development approaches.
CTTI News |

New Resource Highlights Key Insights from the FDA/CTTI Workshop on Artificial Intelligence in Drug and Biological Product Development

A new summary captures key themes and insights from the FDA/CTTI Workshop on Artificial Intelligence in Drug and Biological Product Development, including current and emerging AI applications, implementation challenges, and...
CTTI News |

CTTI Releases Executive Summary from Patient Summit

On April 28, 2026, patients, caregivers, and advocates gathered for the CTTI Patient Summit to discuss perspectives on the use of AI in clinical trials, the reuse of patient data,...
CTTI News |

Designing Trials for the Data We’ll Need Next: Dana Lewis on Participant Burden, Researcher Burden, and Consent in the AI Era

In advance of CTTI’s Patient Summit, Dana Lewis spoke with Morgan Hanger about data capture, consent, researcher assumptions, and why many trials remain anchored in outdated models.

CTTI Work

CTTI Projects

The need for better clinical trials has never been clearer. CTTI unites experts across the clinical trials enterprise to identify challenges, exchange ideas, and develop actionable solutions. Through a collaborative, research-driven approach, CTTI creates evidence-based recommendations and tools that enhance trial quality and efficiency today while advancing a bold vision for the future: Transforming Trials 2030.

Learn More

CTTI_web_projects_banners_18feb20253

CTTI Members

CTTI_web_transform_trials_banners_18feb20252

CTTI Vision

A Bold Vision for 2030

CTTI is driving a future where clinical trials are more efficient, inclusive, and impactful. As we head toward 2030, we’re setting the course for transformation—championing forward-thinking practices, fostering collaboration, and shaping a research ecosystem that delivers better, faster, and more accessible evidence to improve health for all. 

Learn More